4b1830 | Miyarisan Pharmaceutical Co. Ltd represented by Miyarisan Pharmaceutical Europe S.L.U. | Clostridium butyricumFERM BP-2789 | - Additive compositionPreparation of Clostridium butyricum FERM BP-2789 containing a minimum of solid form 5 × 108 CFU/g additive.
- Characterisation of the active substanceClostridium butyricum FERM BP-2789.
- Analytical method
- Quantification: pour plate method based on ISO 15213 standard.
- Identification: pulsed-field gel electrophoresis (PFGE) method.
| Minor avian species (excluding laying birds). | — | 2,5 × 108 | — | 1.In the directions for use of the additive and premixture, indicate the storage temperature, storage life and stability to pelleting.2.The use is allowed in feed containing the authorised coccidiostats: monensin sodium, diclazuril, maduramycin ammonium, robenidine, narasin, narasin/nicarbazin, semduramicin, decoquinate, salinomycin sodium or lasalocid sodium.3.For safety: breathing protection shall be used during the handling. | 6 May 2021 |